Abstract:Transcription factors are key mediators of human complex disease processes. Identifying the target genes of transcription factors will increase our understanding of the biological network leading to disease risk. The prediction of transcription factor binding sites (TFBSs) is one method to identify these target genes; however, current prediction methods need improvement. We chose the transcription factor upstream stimulatory factor l (USF1) to evaluate the performance of our novel TFBS prediction method because of its known genetic association with coronary artery disease (CAD) and the recent availability of USF1 chromatin immunoprecipitation microarray (ChIP-chip) results. The specific goals of our study were to develop a novel and accurate genome-scale method for predicting USF1 binding sites and associated target genes to aid in the study of CAD. Previously published USF1 ChIP-chip data for 1 per cent of the genome were used to develop and evaluate several kernel logistic regression prediction models. A combination of genomic features (phylogenetic conservation, regulatory potential, presence of a CpG island and DNaseI hypersensitivity), as well as position weight matrix (PWM) scores, were used as variables for these models. Our most accurate predictor achieved an area under the receiver operator characteristic curve of 0.827 during cross-validation experiments, significantly outperforming standard PWM-based prediction methods. When applied to the whole human genome, we predicted 24,010 USF1 binding sites within 5 kilobases upstream of the transcription start site of 9,721 genes. These predictions included 16 of 20 genes with strong evidence of USF1 regulation. Finally, in the spirit of genomic convergence, we integrated independent experimental CAD data with these USF1 binding site prediction results to develop a prioritised set of candidate genes for future CAD studies. We have shown that our novel prediction method, which employs genomic features related to the presence of regulatory elements, enables more accurate and efficient prediction of USF1 binding sites. This method can be extended to other transcription factors identified in human disease studies to help further our understanding of the biology of complex disease.

Advances in the Research of the Relationship Between Upstream Transcription Factor 1 Gene and Metabolic Syndrome Related Traits

A Common Polymorphism of Upstream Transcription Factor 1 Gene is Associated with Lipid Profile: A Study in Chinese Type 2 Diabetes Families.

Association of Polymorphisms in the FOXO1 and UCP3 Genes with Nonalcoholic Fatty Liver Disease in Chinese Children

Variation Within the Gene Encoding the Upstream Stimulatory Factor 1 Does Not Influence Susceptibility to Type 2 Diabetes in Samples from Populations with Replicated Evidence of Linkage to Chromosome 1Q

The Role Of Transcription Factor 7-Like 2 In Metabolic Disorders

Systematic analysis reveals distinct roles of USF family proteins in various cancer types

A general integrative genomic feature transcription factor binding site prediction method applied to analysis of USF1 binding in cardiovascular disease

USF1 modulates transcription and cellular functions by regulating multiple transcription factors in Huh7 cells

Linkage and association analyses of the UCP3 gene with obesity phenotypes in Caucasian families.

Association of Genetic Variants in IGF2-Related Genes with Risk of Metabolic Syndrome in the Chinese Han Population

Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1)

Research Progress in Relationship Between Steroidogenic Factor-1 and Metabolic Syndrome

Genetic regulatory and biological implications of the 10q24.32 schizophrenia risk locus

SUMO4 Gene SNP rs237025 and the Synergistic Effect With Weight Management: A Study of Risk Factors and Interventions for MetS

Identification of genetic variants related to metabolic syndrome by next-generation sequencing

Dysregulation of long non-coding RNA ZFAS1 in children with obesity and its predictive value for metabolic syndrome

Three-Dimensional Genome Interactions Identify Potential Adipocyte Metabolism-Associated Gene STON1 and Immune-Correlated Gene FSHR at the rs13405728 Locus in Polycystic Ovary Syndrome

USF1 transcriptionally activates USP14 to drive atherosclerosis by promoting EndMT through NLRC5/Smad2/3 axis

The Expression and Clinical Significance of USF1 in Newly Diagnosed Acute Myeloid Leukemia

Research Progress of the Relationships Between Gene Variations in Chromosome Region 1Q21-Q25 and Type 2 Diabetes Mellitns

Searching for genetic determinants for sodium lithium countertransport, an intermediate trait for essential hypertension